Correction to “Comprehensive Characterization of Bruton’s Tyrosine Kinase Inhibitor Specificity, Potency, and Biological Effects: Insights into Covalent and Noncovalent Mechanistic Signatures”
Abstract
[This corrects the article DOI: 10.1021/acsptsci.4c00540.].
Fields of Study & Subjects
Chronic Lymphocytic Leukemia Research
HER2/EGFR in Cancer Research
Phagocytosis and Immune Regulation
Publication details
- Journal / source
- ACS Pharmacology & Translational Science
- Volume
- 9
- Issue
- 2
- Pages
- 460–460
- Publication date
- 9 January 2026
- Language
- EN